MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC)
Tina Young Poussaint(Seattle Children's Hospital), L. Kun(St. Jude Children's Research Hospital), Mehmet Koçak(St. Jude Children's Research Hospital), Sridhar Vajapeyam, Russell Geyer(St. Jude Children's Research Hospital), Zoltán Patay(St. Jude Children's Research Hospital), Roger Packer(Children's National), J. M. Boyett(University of California, San Francisco), Gilbert Vézina(Children's Oncology Group), Ian F. Pollack(University of Pittsburgh), Soonmee Cha(University of California, San Francisco), Daphne A. Haas‐Kogan(Neurology, Inc), Richard L. Robertson(Neurology, Inc), Robert A. Zimmerman(University of Pennsylvania)
Cited by 103
Related Papers
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Early Experience Alters Brain Function and Structure
|PEDIATRICS|2004|884
Brain Volume and Metabolism in Fetuses With Congenital Heart Disease
|Circulation|2009|659